CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
CURRENT ASSETS:
Cash and cash equivalents	$ 10,062	$ 9,650
Accounts receivable, net of allowance for credit losses of $157 at March 31, 2026 and December 31, 2025	5,740	3,365
Other current assets	893	892
Total current assets	16,695	13,907
PROPERTY AND EQUIPMENT, NET	374	394
GOODWILL	8,102	8,102
INTANGIBLE ASSETS, NET	1,937	2,077
OTHER ASSETS	1	1
Total assets	27,109	24,481
CURRENT LIABILITIES:
Accounts payable	425	226
Accrued expenses	2,229	1,897
Deferred revenue	2,922	1,661
Total current liabilities	5,576	3,784
Total liabilities	5,576	3,784
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock - $0.01 par value; 30,000 shares authorized; Series A convertible preferred stock, zero shares issued and outstanding at March 31, 2026 and December 31, 2025	0	0
Common stock - $0.001 par value; 40,000,000 shares authorized; 20,239,060 and 20,225,323 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	20	20
Additional paid-in capital	154,087	153,887
Accumulated deficit	(132,574)	(133,210)
Total stockholders’ equity	21,533	20,697
Total liabilities and stockholders’ equity	$ 27,109	$ 24,481